Muxin Zhang
Overview
Explore the profile of Muxin Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu Y, Cui X, Lu M, Guan X, Li Y, Zhang L, et al.
Mayo Clin Proc
. 2025 Feb;
100(3):424-439.
PMID: 39918451
Objective: To investigate the causal relationship between various lipid-modifying drugs and new-onset diabetes, as well as the mediators contributing to this relationship. Methods: Mediation Mendelian randomization was performed to investigate...
2.
Cui X, Zhang L, Lin L, Hu Y, Zhang M, Sun B, et al.
Int Immunopharmacol
. 2024 Nov;
143(Pt 3):113574.
PMID: 39520961
Vascular calcification is a significant factor contributing to the rupture of vulnerable atherosclerotic plaques, ultimately leading to cardiovascular disease. However, no effective treatments are currently available to slow the progression...
3.
Li L, Duan L, Xu Y, Ruan H, Zhang M, Zheng Y, et al.
PeerJ
. 2024 Jul;
12:e17760.
PMID: 39006023
Hypertension is one of the most common chronic diseases in older people, and the prevalence is on the rise as the global population ages. Hypertension is closely associated with many...
4.
Li L, Liang Y, Xin D, Liu L, Tan Z, Wang Z, et al.
BMC Public Health
. 2024 May;
24(1):1468.
PMID: 38822311
Background: Hypertension and frailty often coexist in older people. The present study aimed to evaluate the association of frailty status with overall survival in elderly hypertensive patients, using data from...
5.
Hu Y, Lin L, Zhang L, Li Y, Cui X, Lu M, et al.
Hypertension
. 2024 Mar;
81(5):1132-1144.
PMID: 38487880
Background: This study focused on circulating plasma protein profiles to identify mediators of hypertension-driven myocardial remodeling and heart failure. Methods: A Mendelian randomization design was used to investigate the causal...
6.
Lu M, Pan J, Hu Y, Ding L, Li Y, Cui X, et al.
J Nutr Biochem
. 2023 Nov;
124:109531.
PMID: 37984733
Garlic (Allium sativum) is a functional food containing multiple bioactive compounds that find widespread applications in culinary and medicinal practices. It consists of multiple chemical components, including allicin and alliin....
7.
Li L, Ban C, Ruan H, Zhang M, Wang Z, Ma M, et al.
BMC Cardiovasc Disord
. 2023 Nov;
23(1):559.
PMID: 37974066
Background: Albumin to fibrinogen ratio (AFR), a new inflammatory marker, has emerged as a useful indicator to predict adverse outcomes for several diseases. However, whether AFR could be a new...
8.
Zhang Z, Zhang M, Xu Y, Lu M, Zhang L, Li C
Front Pharmacol
. 2023 Oct;
14:1226008.
PMID: 37854719
Astragaloside IV (ASIV) is the primary pharmacologically active compound found in Schischkin, which has potential protective effects on cardiac function. However, there are almost no systematic evaluations of ASIV for...
9.
Zhou C, Shen S, Zhang M, Luo H, Zhang Y, Wu C, et al.
Front Med (Lausanne)
. 2023 Sep;
10:1235081.
PMID: 37700771
Osteoporosis (OP) is a systemic skeletal disease prevalent in older adults, characterized by substantial bone loss and deterioration of microstructure, resulting in heightened bone fragility and risk of fracture. Traditional...
10.
Huang X, Zhang M, Song Y, Sun B, Lin L, Song X, et al.
J Cell Mol Med
. 2023 Aug;
27(22):3514-3525.
PMID: 37643320
Salvia miltiorrhiza Bunge is a natural drug for treating myocardial infarction (MI). However, the targets and mechanisms of S. miltiorrhiza Bunge in the treatment of MI are yet to be...